Conference Background - The conference organized by the Shanghai Branch of the Chinese Academy of Sciences aims to create a platform for young scientific talents to exchange and collaborate, focusing on interdisciplinary integration and promoting technological innovation in the fields of material chemistry, optoelectronic information, and life health [3]. Conference Information - The conference will take place from August 18 to 20, 2025, at the Ningbo Institute of Materials Engineering, with over 300 participants expected [4]. - The event is hosted by the Shanghai Branch of the Chinese Academy of Sciences, co-organized by the Ningbo Institute of Materials Technology and Engineering, and managed by Nanjing Detai Zhongyan Information Technology Co., Ltd [4]. Conference Agenda - The agenda includes a registration forum on August 18, an opening ceremony and keynote speeches on August 19, followed by various sub-forums dedicated to material chemistry, optoelectronic information, and life health on both August 19 and 20 [6]. Sub-Forum Topics - Sub-Forum 1: Material Chemistry focuses on topics such as information functional nanomaterials and materials characterization with computational chemistry [7]. - Sub-Forum 2: Optoelectronic Information covers advanced optoelectronic materials and devices, high-speed optical modules, and artificial intelligence [8]. - Sub-Forum 3: Life Health discusses precision drug delivery, intelligent medical imaging, and new medical devices [9][12]. Registration Information - The registration fee is set at 1800 yuan per participant and 1200 yuan for student representatives, with electronic invoices provided post-conference [11]. - Registration can be completed via a WeChat scan, with a deadline of August 15, 2025 [13]. Contact Information - For inquiries, contact Hu Junqin at 18106696283 (WeChat) or via email at cherry@polydt.com [14].

在精准帮扶企业方面，《方案》提出以外贸企业为重点，深入了解各行业企业生产经营情况，统筹政 策、资源、资金帮助企业消化库存、开拓市场、降低成本，着力解决企业实际困难。 广州实施"久摇不中"申请人直接领取号牌政策，更大力度放宽购车限制性措施、增加购车指标；深圳市 优化小汽车常规增量指标摇号规则，加强"久摇不中"人群购车需求保障。 扩大科研助理和见习岗位规模，2025年提供不少于1万个科研助理岗位。 加快广州、深圳市内免税店建设，力争在2025年第三季度内开业。 6月24日，《广东省促进经济持续向好服务做强国内大循环工作方案》（以下简称"《方案》"）公布， 提出七项重点任务及多项细化部署，统筹实施扩大内需战略和深化供给侧结构性改革，着力稳就业、稳 企业、稳市场、稳预期，促进经济持续向好，有力服务做强国内大循环。 多项措施帮助企业对接国外市场 出台措施促进经济持续向好 有力服务做强国内大循环 《方案》提出，筹划以市场化办展模式举办内贸版"广交会"；支持电商企业设立出口转内销专区；支持 办好第二十届中国国际中小企业博览会等重大活动。 推动散裂中子源一期等向企业开放共享 从具体措施来看，《方案》提出筹划以市场化办展模式举 ...

Core Viewpoint - A significant number of American researchers are considering leaving the U.S. due to drastic cuts in research funding, with over 75% contemplating relocation, particularly to Europe and Canada [1][2][10]. Funding Cuts - The U.S. has seen severe reductions in research budgets, with the National Institutes of Health (NIH) budget cut by 40% and the National Science Foundation (NSF) budget slashed by 57% [4][5]. - Other fields have also experienced substantial funding cuts, with biology, engineering, and education seeing reductions of over 70%, while computer science, mathematics, and physics faced cuts of 60% [8]. Talent Migration - The increase in American researchers seeking opportunities abroad is notable, with applications to Europe rising by 32% and interest in Canadian positions increasing by 41% [1][10]. - European countries are actively trying to attract American talent, with the EU planning to add €500 million in budget from 2025 to 2027 to enhance their appeal to researchers [12]. Chinese Recruitment - China is also in the race to attract American scientists, particularly targeting those of Chinese descent, with a significant increase in the number of Chinese scientists returning to China [13][15]. - From 2010 to 2021, nearly 20,000 Chinese scientists left the U.S., with a 75% increase in departures after 2018, largely due to the "China Initiative" that targeted Chinese researchers [15]. Global Research Landscape Shift - The ongoing talent exodus from the U.S. is indicative of a larger shift in the global research landscape, with countries like Japan and institutions in Hong Kong also ramping up efforts to recruit international scholars [22][23]. - The historical dominance of the U.S. in global research is being challenged, as the country dismantles its long-standing research networks, leading to a potential reconfiguration of scientific leadership worldwide [25].

Core Insights - The first research instrument open-sharing loss compensation insurance has been implemented in Suzhou, providing over 4 million yuan in risk coverage for shared scientific equipment [1][2] - The initiative addresses long-standing issues related to damage liability, making it easier for institutions to share high-end research instruments [1][2] Group 1: Insurance Implementation - The insurance scheme integrates a "sharing economy + technology insurance" model, covering risks from design defects, installation errors, and operational mistakes [2] - This measure alleviates safety concerns for instrument-holding units and removes barriers for small and medium-sized innovative enterprises in utilizing high-end equipment [2] Group 2: Impact on Research and Development - The insurance boosts confidence among research teams to fully utilize high-end equipment in their testing services, enabling them to provide more comprehensive and advanced testing services to enterprises [2] - The local technology department plans to collaborate with instrument management departments, universities, and maintenance units to promote further sharing of research instruments, enhancing the efficiency of technological resource sharing [2]

Core Insights - A new study from MIT reveals that bacterial biofilms play a crucial role in determining the accumulation of microplastics in riverbeds, making them more susceptible to being washed away by water flow [1][2] - The presence of biofilms reduces the space available for microplastics to embed within sand particles, thus increasing their exposure to water flow and facilitating their removal [2] Group 1 - Microplastics are increasingly concerning due to their accumulation in the environment and human bodies, complicating pollution management efforts [1] - The study published in "Geophysical Research Letters" highlights that biofilms are key factors influencing microplastic distribution and sedimentation [1] - The research utilized a flume experiment to simulate conditions affecting microplastic behavior, demonstrating the impact of biofilms on microplastic accumulation [1][2] Group 2 - The study identified two phenomena affecting microplastic accumulation: turbulence around simulated root systems hinders sedimentation, while increased biofilm content reduces microplastic accumulation [2] - Biofilms fill the gaps between sand particles, making it difficult for microplastics to embed and thus more likely to be carried away by water flow [2] - The researchers suggest that monitoring efforts should focus on sandy outer regions of mangrove ecosystems, where microplastics are likely to accumulate due to lower biofilm presence [2]

原标题："干得好不好，企业说了算" 此外，松绑减负还体现在不增加额外管理负担等方面。曾有科研人员向记者抱怨，自己受聘于企 业，工作之余要填写工作日志，年底还要接受考核检查，耗费了不少精力。出发点虽好，但无形中给科 研人员增加了负担。 鼓励科研人员深入企业一线，要处理好管理与服务的关系。遵循这一思路，宁夏科技厅此次特地简 化程序，组织开发自治区科创专员选聘工作网络版服务平台，全面推行申报无纸化，实现选聘工作全流 程信息化。 当前，企业科技创新能力弱是宁夏产业创新发展的突出短板。企业普遍面临科技人才短缺、创新效 能不高等问题，通过让科研人员"下沉"一线等举措提升核心竞争力，迫在眉睫。 首批科创专员来自宁夏大学、宁夏农林科学院等8家区内高校院所，以及山东大学、西安交通大 学、中国水产科学研究院、苏州英诺欣医药科技有限公司等25家区外单位。 宁夏此次改革的关键，在于既要激励科研人员深入企业"摸爬滚打"，又要避免给他们造成额外负 担，实现二者的平衡。 记者翻阅选聘管理办法时注意到，支持政策规定"对于选聘的科创专员，通过自治区人才经费每年 给予2万元生活补助"，这与常见的科技项目经费截然不同。 "传统模式下，科研人员花的 ...

导读： 经浙江省科学技术厅组织评审和论证，认定"全省智能建造与工程软件重点实验室"等137家为全省重点实验室。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 各有关单位： 为落实省委、省政府决策部署，整合力量打造科技创新平台，加强科技基础能力建设，提升基础研究和原始创新能力，支撑构建现代化产业体 系，根据《全省重点实验室管理办法》（浙科发基〔2 0 2 3〕4 0号）规定，经我厅组织评审和论证，认定" 全省智能建造与工程软件重点实验 室"等1 3 7家为全省重点实验室（以下简称"实验室"）。现将有关事项通知如下： 一、强化责任担当。重组后的实验室，要切实增强在相关创新链中"总平台、总链长"的使命感，深入推动教科人一体融合，推动科研成果转化 产业化，推进科技开放合作，提高基础研究组织化程度，强化核心能力，提升建设效能，在增强创新体系一体化能力中发挥核心作用。 二、强化服务监督。各实验室主管部门和依托单位要指导实验室运行和管理，给予持续、稳定的科研投入，在人事、财务、科研组织等方面赋 予更大自主权，协调解决建设、运行中存在的困难和问题，督促完 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report highlights the significant progress in the Protac self-immune track, particularly with Kymera's STAT6 degrader molecule KT-621, which has shown complete degradation of the STAT6 target in both blood and skin at doses of ≥50mg. This molecule has the potential to treat Th2 inflammatory diseases and has demonstrated safety and efficacy comparable or superior to Dupilumab [4][11] - The pharmaceutical and biotechnology sector saw a 1.13% increase in the first week of June 2025, outperforming the CSI 300 index by 0.25 percentage points, ranking 17th among 31 sub-industries [5][14] Summary by Relevant Sections Protac Self-Immune Track Progress - Kymera's KT-621 has achieved complete degradation of the STAT6 target, which is crucial for treating Th2 type inflammatory diseases. The early efficacy and safety data are promising, and further data from patient populations are expected in the next 6-12 months [4][11][12] Market Performance - In the first week of June 2025, the pharmaceutical sector increased by 1.13%, with the raw material drug sector showing the highest growth at 2.89%. Other sectors such as blood products and in vitro diagnostics also performed well, while other biological products experienced a slight decline [5][18][20] - The report indicates that the overall market has been on a downward trend since the beginning of 2025, but the pharmaceutical sector has managed to maintain a positive trajectory [14][22] Recommended and Benefiting Stocks - Recommended stocks in the pharmaceutical and biotechnology sectors include: Heng Rui Medicine, East China Medicine, Sanofi Pharmaceutical, and others. In the CXO category, companies like WuXi AppTec and Tigermed are highlighted. The report also lists various companies across different sub-sectors such as traditional Chinese medicine, raw materials, medical devices, and retail pharmacies [5][24]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report highlights the significant progress in the Protac self-immune track, particularly with Kymera's STAT6 degrader molecule KT-621, which has shown complete degradation of the STAT6 target in both blood and skin at doses of ≥50mg. This molecule has the potential to treat Th2 inflammatory diseases and has demonstrated safety and efficacy comparable or superior to Dupilumab [4][11] - The pharmaceutical and biotechnology sector saw a 1.13% increase in the first week of June 2025, outperforming the CSI 300 index by 0.25 percentage points, ranking 17th among 31 sub-industries [5][14] Summary by Relevant Sections 1. Protac Self-Immune Track Progress - Kymera's KT-621 has achieved complete degradation of the STAT6 target, which is crucial for treating Th2 type inflammatory diseases. The early efficacy and safety data are promising, with further data expected in the coming 6-12 months [4][11][12] 2. Market Performance - In the first week of June 2025, the pharmaceutical sector rose by 1.13%, with the raw material drug sector showing the highest increase of 2.89%. Other sectors such as blood products and in vitro diagnostics also performed well, while other biological products saw a slight decline [5][18][20] 3. Recommended and Benefiting Stocks - Recommended stocks include major pharmaceutical and biotechnology companies such as Heng Rui Medicine, Huadong Medicine, and others across various segments including CXO, research services, traditional Chinese medicine, raw materials, medical devices, and retail pharmacies [5][24]

Group 1 - The provincial human resources and social security department has selected and published 512 postdoctoral research positions to attract outstanding young doctoral talents from home and abroad [1] - The province has rich scientific and educational resources, with 132 postdoctoral research flow stations, 138 postdoctoral research workstations, and 242 postdoctoral innovation practice bases across various disciplines and industries [1] - The published 512 postdoctoral positions include 352 positions from flow stations and 160 positions from workstations and innovation practice bases, covering fields such as software engineering, information and communication engineering, naval and ocean engineering, pharmacy, and ecology [1] Group 2 - The province has introduced policies and benefits for postdoctoral researchers, including a reward of 300,000 yuan for those with a PhD from a globally ranked top 200 university who sign a full-time contract for over three years [2] - New postdoctoral researchers entering enterprise workstations or innovation practice bases will receive a reward of 100,000 yuan, while newly established postdoctoral flow stations and workstations will receive 150,000 yuan [2] - Local governments have also announced policies regarding funding conditions, standards, living subsidies, family placement, and children's education to ensure postdoctoral researchers can focus on their research work [2]